An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Leveling the Playing Field at AAA 2026
Wednesday, April 22 | 12:30–2:00 pm Earn 0.15 CEUs Concussion care is no longer a single-discipline effort. As research continues to reveal concussion as a…
How to Get Patient Referrals through Your ABA Certification
Did you know that ABA publishes directories for each certification and certificate program on its website? Credential holders are sorted alphabetically by country, and then…
Update: General Audiology Board Certification Is Coming
Progress continues on the new General Audiology Board Certification (GABC) that will lead to a Board Certified Audiologist (BC-A) credential. The Development Task Force has…


